Search for Clinical Trial Results

Sponsored By

Neovascularization, Pathologic - 5 Studies Found

Status Study
Completed Study Name: 68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis
Condition: Pathological Angiogenesis
Date: 2016-01-24
Interventions:
  • Radiation: 68Ga-NODAGA-RGD PET/CT

Completed Study Name: Ranibizumab for Myopic Neovascularization
Condition: Myopic Choroidal Neovascularization
Date: 2010-11-20
Interventions: Drug: ranibizumab injection Ranibizumab intravitreal injection of 0,5 mg ( 0.05mL)
Completed Study Name: Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization
Condition: Choroidal Retinal Neovascularization
Date: 2013-12-31
Interventions: Drug: Aflibercept Injection Aflibercept intravitreal injection
Active, not recruiting Study Name: Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia
Condition: Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia
Date: 2012-10-25
Interventions: Drug: Bevazizumab intravitreal injection Intravitreal injection of bevacizumab
Active, not recruiting Study Name: Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular Diseases
Condition: Neovascularization, Pathologic
Date: 2015-05-15
Interventions: Drug: ACM-1 intravitreal injection with 50ul ACM-1 at a concentration of 1600ug/ml